<?xml version="1.0" encoding="UTF-8"?>
<patent-document ucid="EP-2681997-A1" country="EP" doc-number="2681997" kind="A1" date="20140108" family-id="46044131" file-reference-id="311173" date-produced="20180822" status="corrected" lang="EN"><bibliographic-data><publication-reference fvid="146585610" ucid="EP-2681997-A1"><document-id><country>EP</country><doc-number>2681997</doc-number><kind>A1</kind><date>20140108</date><lang>EN</lang></document-id></publication-reference><application-reference ucid="EP-12719247-A" is-representative="YES"><document-id mxw-id="PAPP154847802" load-source="docdb" format="epo"><country>EP</country><doc-number>12719247</doc-number><kind>A</kind><date>20120227</date><lang>ES</lang></document-id><document-id mxw-id="PAPP173923806" load-source="docdb" format="original"><country>EP</country><doc-number>12719247.4</doc-number><date>20120227</date><lang>ES</lang></document-id></application-reference><priority-claims><priority-claim mxw-id="PPC140547523" ucid="CU-20110046-A" load-source="docdb"><document-id format="epo"><country>CU</country><doc-number>20110046</doc-number><kind>A</kind><date>20110228</date></document-id></priority-claim><priority-claim mxw-id="PPC140553692" ucid="CU-2012000001-W" linkage-type="W" load-source="docdb"><document-id format="epo"><country>CU</country><doc-number>2012000001</doc-number><kind>W</kind><date>20120227</date></document-id></priority-claim></priority-claims><technical-data><classifications-ipcr><classification-ipcr mxw-id="PCL-1889107166" load-source="docdb">A01N  65/08        20090101ALI20161006BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-1889107167" load-source="docdb">A01N  49/00        20060101ALI20161006BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-1889107168" load-source="docdb">A01N  43/90        20060101ALI20161006BHEP        </classification-ipcr><classification-ipcr mxw-id="PCL-1889107169" load-source="docdb">A01N  43/22        20060101AFI20161006BHEP        </classification-ipcr></classifications-ipcr><classifications-cpc><classification-cpc mxw-id="PCL-2056022986" load-source="docdb" scheme="CPC">A01N  65/08        20130101 LI20150511BHEP        </classification-cpc><classification-cpc mxw-id="PCL1989631310" load-source="docdb" scheme="CPC">A01N  49/00        20130101 LI20131204BHEP        </classification-cpc><classification-cpc mxw-id="PCL2026855972" load-source="docdb" scheme="CPC">A01N  43/90        20130101 LI20140214BHEP        </classification-cpc><classification-cpc mxw-id="PCL2090176840" load-source="docdb" scheme="CPC">A01N  43/22        20130101 FI20140620BHEP        </classification-cpc></classifications-cpc><invention-title mxw-id="PT132361463" lang="DE" load-source="patent-office">VERFAHREN ZUR INDUKTION VON RESISTENZ GEGEN KRANKHEITEN BEI PFLANZEN</invention-title><invention-title mxw-id="PT132361464" lang="EN" load-source="patent-office">METHOD FOR INDUCING RESISTANCE TO DISEASES IN PLANTS</invention-title><invention-title mxw-id="PT132361465" lang="FR" load-source="patent-office">PROCÉDÉ POUR INDUIRE UNE RÉSISTANCE AUX MALADIES CHEZ LES PLANTES</invention-title></technical-data><parties><applicants><applicant mxw-id="PPAR919529534" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>CT INGENIERIA GENETICA BIOTECH</last-name><address><country>CU</country></address></addressbook></applicant><applicant mxw-id="PPAR919521722" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>CENTRO DE INGENIERIA GENETICA Y BIOTECNOLOGIA</last-name></addressbook></applicant><applicant mxw-id="PPAR919017636" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Centro De Ingenieria Genetica Y Biotecnologia</last-name><iid>101036957</iid><address><street>Avenida 31 entre 158 y 190 Cubanacán Playa</street><city>Ciudad de la Habana 10600</city><country>CU</country></address></addressbook></applicant></applicants><inventors><inventor mxw-id="PPAR919528639" load-source="docdb" sequence="1" format="epo"><addressbook><last-name>BORRAS HIDALGO ORLANDO</last-name><address><country>CU</country></address></addressbook></inventor><inventor mxw-id="PPAR919544965" load-source="docdb" sequence="1" format="intermediate"><addressbook><last-name>BORRAS HIDALGO, ORLANDO</last-name></addressbook></inventor><inventor mxw-id="PPAR919018050" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>BORRÁS HIDALGO, Orlando</last-name><address><street>Calle 186, No 3117, Apto 9I, e/ 31 y 33 Cubanacán Playa</street><city>La Habana 11600</city><country>CU</country></address></addressbook></inventor><inventor mxw-id="PPAR919522400" load-source="docdb" sequence="2" format="epo"><addressbook><last-name>CANALES LOPEZ EDUARDO</last-name><address><country>CU</country></address></addressbook></inventor><inventor mxw-id="PPAR919516275" load-source="docdb" sequence="2" format="intermediate"><addressbook><last-name>CANALES LOPEZ, EDUARDO</last-name></addressbook></inventor><inventor mxw-id="PPAR919008253" load-source="patent-office" sequence="2" format="original"><addressbook><last-name>CANALES LÓPEZ, Eduardo</last-name><address><street>Calle 170, Edif. BCE1, apto. 18 entre 1ra y 5ta, Playa</street><city>La Habana 11600</city><country>CU</country></address></addressbook></inventor><inventor mxw-id="PPAR919507587" load-source="docdb" sequence="3" format="epo"><addressbook><last-name>PUJOL FERRER MERARDO</last-name><address><country>CU</country></address></addressbook></inventor><inventor mxw-id="PPAR919513541" load-source="docdb" sequence="3" format="intermediate"><addressbook><last-name>PUJOL FERRER, MERARDO</last-name></addressbook></inventor><inventor mxw-id="PPAR919011458" load-source="patent-office" sequence="3" format="original"><addressbook><last-name>PUJOL FERRER, MERARDO</last-name><address><street>Calle 186, No 3115, Apto 6C, e/ 31 y 33 Cubanacán Playa</street><city>La Habana 11600</city><country>CU</country></address></addressbook></inventor><inventor mxw-id="PPAR919535366" load-source="docdb" sequence="4" format="epo"><addressbook><last-name>BORROTO NORDELO CARLOS GUILLERMO</last-name><address><country>CU</country></address></addressbook></inventor><inventor mxw-id="PPAR919504678" load-source="docdb" sequence="4" format="intermediate"><addressbook><last-name>BORROTO NORDELO, CARLOS, GUILLERMO</last-name></addressbook></inventor><inventor mxw-id="PPAR919014084" load-source="patent-office" sequence="4" format="original"><addressbook><last-name>BORROTO NORDELO, CARLOS, GUILLERMO</last-name><address><street>Ave 19-A, No. 21414, entre 214 y 216 Atabey Playa</street><city>La Habana 11600</city><country>CU</country></address></addressbook></inventor><inventor mxw-id="PPAR919543154" load-source="docdb" sequence="5" format="epo"><addressbook><last-name>COLL GARCIA YAMILET</last-name><address><country>CU</country></address></addressbook></inventor><inventor mxw-id="PPAR919505517" load-source="docdb" sequence="5" format="intermediate"><addressbook><last-name>COLL GARCIA, YAMILET</last-name></addressbook></inventor><inventor mxw-id="PPAR919010111" load-source="patent-office" sequence="5" format="original"><addressbook><last-name>COLL GARCÍA, Yamilet</last-name><address><street>Calle 112, No. 515, entre 5ª B y 5ª F, Playa</street><city>La Habana 11600</city><country>CU</country></address></addressbook></inventor></inventors><agents><agent mxw-id="PPAR919010087" load-source="patent-office" sequence="1" format="original"><addressbook><last-name>Jansen, Cornelis Marinus</last-name><suffix>et al</suffix><iid>101226155</iid><address><street>V.O. Johan de Wittlaan 7</street><city>2517 JR Den Haag</city><country>NL</country></address></addressbook></agent></agents></parties><international-convention-data><pct-or-regional-filing-data ucid="CU-2012000001-W"><document-id><country>CU</country><doc-number>2012000001</doc-number><kind>W</kind><date>20120227</date><lang>ES</lang></document-id></pct-or-regional-filing-data><pct-or-regional-publishing-data ucid="WO-2012116664-A1"><document-id><country>WO</country><doc-number>2012116664</doc-number><kind>A1</kind><date>20120907</date><lang>ES</lang></document-id></pct-or-regional-publishing-data><designated-states><ep-contracting-states><country mxw-id="DS549827305" load-source="docdb">AL</country><country mxw-id="DS549749797" load-source="docdb">AT</country><country mxw-id="DS549827310" load-source="docdb">BE</country><country mxw-id="DS549830570" load-source="docdb">BG</country><country mxw-id="DS549910940" load-source="docdb">CH</country><country mxw-id="DS549822102" load-source="docdb">CY</country><country mxw-id="DS549749798" load-source="docdb">CZ</country><country mxw-id="DS549827311" load-source="docdb">DE</country><country mxw-id="DS549822103" load-source="docdb">DK</country><country mxw-id="DS549822104" load-source="docdb">EE</country><country mxw-id="DS549753639" load-source="docdb">ES</country><country mxw-id="DS549830571" load-source="docdb">FI</country><country mxw-id="DS549827684" load-source="docdb">FR</country><country mxw-id="DS549827312" load-source="docdb">GB</country><country mxw-id="DS549822105" load-source="docdb">GR</country><country mxw-id="DS549827313" load-source="docdb">HR</country><country mxw-id="DS549749799" load-source="docdb">HU</country><country mxw-id="DS549910941" load-source="docdb">IE</country><country mxw-id="DS549822110" load-source="docdb">IS</country><country mxw-id="DS549827685" load-source="docdb">IT</country><country mxw-id="DS549822111" load-source="docdb">LI</country><country mxw-id="DS549830572" load-source="docdb">LT</country><country mxw-id="DS549751047" load-source="docdb">LU</country><country mxw-id="DS549830573" load-source="docdb">LV</country><country mxw-id="DS549830578" load-source="docdb">MC</country><country mxw-id="DS549751048" load-source="docdb">MK</country><country mxw-id="DS549751053" load-source="docdb">MT</country><country mxw-id="DS549827318" load-source="docdb">NL</country><country mxw-id="DS549827690" load-source="docdb">NO</country><country mxw-id="DS549830579" load-source="docdb">PL</country><country mxw-id="DS549910942" load-source="docdb">PT</country><country mxw-id="DS549827319" load-source="docdb">RO</country><country mxw-id="DS549910943" load-source="docdb">RS</country><country mxw-id="DS549830580" load-source="docdb">SE</country><country mxw-id="DS549753640" load-source="docdb">SI</country><country mxw-id="DS549827691" load-source="docdb">SK</country><country mxw-id="DS549830581" load-source="docdb">SM</country><country mxw-id="DS549822112" load-source="docdb">TR</country></ep-contracting-states></designated-states></international-convention-data></bibliographic-data><abstract mxw-id="PA128673782" lang="EN" load-source="patent-office"><p id="pa01" num="0001">The present invention describes a method for the stimulation of the natural defense and the induction of resistance to diseases in plants by simultaneous activation of genes related to the route of the salicylic acid, the jasmonic acid/ethylene and the hypersensitive response. The invention also includes the use of brassinosteroids for the preventive and curative treatment against plant diseases caused by pathogens. In addition, includes a method for the prevention and treatment of the Huanglongbing disease in citrus.</p></abstract><abstract mxw-id="PA128737942" lang="EN" source="EPO" load-source="docdb"><p>The present invention describes a method for the stimulation of the natural defense and the induction of resistance to diseases in plants by simultaneous activation of genes related to the route of the salicylic acid, the jasmonic acid/ethylene and the hypersensitive response. The invention also includes the use of brassinosteroids for the preventive and curative treatment against plant diseases caused by pathogens. In addition, includes a method for the prevention and treatment of the Huanglongbing disease in citrus.</p></abstract><description mxw-id="PDES63959770" lang="EN" load-source="patent-office"><!-- EPO <DP n="1"> --><heading id="h0001"><b>Field of the Invention</b></heading><p id="p0001" num="0001">The present invention is related to the agricultural biotechnology field, specifically to the stimulation of the natural defense and the induction of resistance to diseases in plants, to avoid or to fight the diseases caused by pathogens.</p><heading id="h0002"><b>Previous Art</b></heading><p id="p0002" num="0002">In recent decades many studies have been made about plant - pathogen interactions, from morphological, physiological, biochemical and molecular point of view. However, the results achieved to date do not meet the needs and knowledge of the major research groups in the world, and high yields through a stable and efficient protection of crops is not accomplish. Despite the numerous measures taken globally for an integrated crops protection, major crop losses from disease reaching 80% of production are reported each year, specifically in situations where epidemics occur (<nplcit id="ncit0001" npl-type="s"><text>Gao et al. (2000) Nature Biotechnol. 18: 1307-1310</text></nplcit>).</p><p id="p0003" num="0003">Plants and pathogens have co-evolved over millions of years. During this interaction, strategies have emerged that allow plants to recognize potential invading pathogens and trigger a successful defense. Likewise, pathogens have developed mechanisms that enable them to evade and/or suppress plant defense responses. The influence of this selective pressure on plants has led to the improvement of their defense mechanisms. As a result, the success of the pathogen to cause disease, far from being the rule is an exception (<nplcit id="ncit0002" npl-type="s"><text>Staskawicz (2001) Plant Physiology 125: 73-76</text></nplcit>).</p><p id="p0004" num="0004">The perception of specific and general elicitors by plants not only allows the recognition of pathogens, but allows the transduction of signals for the activation of response mechanisms. Among the various signaling pathways activated are those mediated by intermediates such as reactive oxygen, salicylic acid, ethylene and jasmonic acid. The crossover between these phytohormones signaling pathways provides a regulatory potential that allow activation of an optimal combination of responses depending on the specific pathogen. The expression of genes related to pathogenicity (PR) and the synthesis of antimicrobial compounds that are generally phytoalexins, defensins, phenolics and flavonoids produced to directly attack the pathogen are also activated (<nplcit id="ncit0003" npl-type="s"><text>Baker et al. (1997) Science 276: 726-733</text></nplcit>).</p><p id="p0005" num="0005">There are other response mechanisms that operate in plants, whose effects persist for a relatively long period of time after infection. These are called: acquired localized<!-- EPO <DP n="2"> --> response and systemic acquired response. Acquired localized response is observed in a ring of cells, 5-10 mm thick, about injuries caused by the hypersensitive response. This area is characterized by a large accumulation of pathogenesis-related proteins, mainly basic (<nplcit id="ncit0004" npl-type="s"><text>Fritig et al. (1998) Current Opinion of Immunology 10: 16-22</text></nplcit>) and stimulation of enzymes such as methyltransferases (<nplcit id="ncit0005" npl-type="s"><text>Legrand et al. (1978) Planta 144: 101-108</text></nplcit>), the phenylpropanoid pathway, which is involved in the production of antibiotics such as scopoletin, which does not provide a suitable environment for pathogens, preventing their spread throughout the plant. Systemic acquired response gives the plant a higher level of resistance against a subsequent infection of the same pathogen. It develops not only in infected tissues, but throughout the plant. It is characterized by the accumulation of PR proteins, particularly acidic, which are related to the signaling mechanism of salicylic acid (<nplcit id="ncit0006" npl-type="s"><text>Cordelier et al. (2003) Plant Molecular Biology 51 : 109 - 118</text></nplcit>).</p><p id="p0006" num="0006">Plants have the ability to synthesize a variety of steroids that function as hormones. However, it was not until 1979 that the presence of steroid hormones was confirmed in plants. In that year, American scientists published data on a new steroidal lactone called brassinolide, which was isolated from <i>Brassica napus</i> L. pollen (<nplcit id="ncit0007" npl-type="s"><text>Grove et al. (1979) Nature 281: 216-217</text></nplcit>). The brassinosteroids have been recognized as a new class of phytohormones that play an important role in growth regulation (<nplcit id="ncit0008" npl-type="s"><text>Azpiroz et al. (1998) Plant Cell 10: 219-230</text></nplcit>). The physiological properties of brassinosteroids allow us to consider them as very promising for use without impacting the environment. Natural substances may be suitable for wide application in plant protection and promotion of efficiency in agriculture.</p><p id="p0007" num="0007">From the beginning the brassinosteroids were considered promising compounds for application in agriculture because they showed different types of regulatory activity in the growth and development of plants, and its economic value as an advocate of performance (<nplcit id="ncit0009" npl-type="s"><text>Khripach et al. (2000) Ann. Botany 86: 441-447</text></nplcit>). An important feature is the ability of brassinosteroids to act in extremely low concentrations. An indirect confirmation of this phenomenon is the low concentration of brassinosteroids in plants. A typical amount for use in agriculture is between 5 and 50 mg per hectare for growing plants (<nplcit id="ncit0010" npl-type="s"><text>Khripach et al. (2000) Ann. Botany 86: 441-447</text></nplcit>).</p><p id="p0008" num="0008">The brassinosteroids can also play a role in the response of plants to pathogens. Resistance to bacterial and fungal pathogens have been induced by brassinosteroids in rice and tobacco, this resistance was not correlated with<!-- EPO <DP n="3"> --> increased accumulation of salicylic acid or increased expression of genes associated with systemic acquired resistance (<nplcit id="ncit0011" npl-type="s"><text>Nakashita et al. (2003) Plant Journal 33: 887-898</text></nplcit>).</p><p id="p0009" num="0009">The "Huanglongbing" (HLB) caused by the bacterium <i>Candidatus</i> 'Liberibacter asiaticus' is the most destructive disease of citrus worldwide by the severity of symptoms, the speed with which it spreads and affects all commercial citrus species. It is a disease that still has no cure (<nplcit id="ncit0012" npl-type="s"><text>Gottwald (2010) Annu. Rev. Phytopathol. 48: 6.1-6.21</text></nplcit>). The disease was first detected in Asia in the late nineteenth century, and then its presence was reported in South Africa in the early twentieth century, which helped the spreading in both continents through the years (<nplcit id="ncit0013" npl-type="s"><text>Gottwald (2010) Annu. Rev. Phytopathol. 48: 6.1-6.21</text></nplcit>). Currently three variants of the disease are recognized (Asian, African and American). The causal organism is a "fastidious" gram-negative bacterium, which can not be obtained in pure culture on artificial media. This organism is restricted to the phloem of <i>Rutaceae,</i> although it has the ability to multiply in the hemolymph and salivary glands of the psyllid vectors (Asian citrus psyllid - <i>Diaphorina citri</i>)<i>.</i> In insects, it penetrates the intestinal wall to reach the salivary glands, via hemolymph in a period of 1 to 3 weeks depending on the virulence of the strain.</p><p id="p0010" num="0010">Symptoms vary with the variety and age of the affected plant, as these are clearly observed in young and vigorous trees, while those affected after development, present less marked symptoms. In matured leaves, the tissues along the midrib and secondary veins become yellow and chlorosis spreads on the lateral veins until the leaf falls (<nplcit id="ncit0014" npl-type="s"><text>da Graca (1991) Annu. Rev. Phytopathol. 29:109 -36</text></nplcit>). The process is more severe in young leaves, which remain small in size. Plants show a considerable defoliation with apical death a few years after infection, mottling and yellowing are also generalized. They develop multiple shoots with small leaves, pale and mottled. During the infection there is a poor fruit set, early dropping of these and those who remain on the tree are small and asymmetric, taking the correct color only the side expose to sunlight, while the other side takes an intense olive-green coloration (<nplcit id="ncit0015" npl-type="s"><text>Bové J (2006) Plant Pathol. 88: 7-37</text></nplcit>). The fruits have a low amount of juice, and a low concentration of soluble solids and sugars, becoming highly acidic and not suitable to be used in industry (<nplcit id="ncit0016" npl-type="s"><text>Gottwald (2010) Annu. Rev. Phytopathol. 48: 6.1-6.21</text></nplcit>).<!-- EPO <DP n="4"> --></p><p id="p0011" num="0011">The economic impact for the presence of HLB in citrus - producing countries has increased year by year, with losses estimated in about a 30-100%, due to reduced yields and fruit quality. Until now, there is no region in the world where the HLB is adequately controlled and the disease does not exist, which contributes to increase its severity and incidence (<nplcit id="ncit0017" npl-type="s"><text>Gottwald (2010) Annu. Rev. Phytopathol. 48: 6.1-6.21</text></nplcit>). Recently, the use of systemic acquired resistance have been evaluated by using compounds such as salicylic acid and phosphite in combination with micronutrients to maintain HLB-infected trees in a productive state. However, in some cases, there was not a significant difference between treated and untreated trees, in relation to the decrease of HLB, fruit drop, yield and quality (<nplcit id="ncit0018" npl-type="s"><text>Gottwald (2010) Annu. Rev. Phytopathol. 48: 6.1-6.21</text></nplcit>).</p><p id="p0012" num="0012">Therefore, an important problem that remains in agriculture is the control of plant diseases, which limit agricultural production each year worldwide.</p><heading id="h0003"><b>Detailed description of the invention</b></heading><p id="p0013" num="0013">This invention helps to solve the above mentioned problem by providing an effective method for stimulating the natural defense and the induction of resistance to diseases in plants, by applying a compound that simultaneously activate genes related to the route of salicylic acid, jasmonic acid/ethylene and hypersensitive response in them.</p><p id="p0014" num="0014">Induction of resistance to diseases is a method of great importance and interest at present, which allows the use of biochemical and molecular mechanisms that already exist in the plant for use in disease control. The defense of plants to diseases comprises a series of events related to the recognition, signaling and response defined as innate immunity in plants. This innate immunity can be activated by a number of factors, which decisively contribute to the disease control. Among the defense mechanisms that are activated by the plant is the synthesis of antimicrobial phytoalexins, defensins and pathogenesis-related proteins. These responses are mediated by activation of genes related to salicylic acid, jasmonic acid/ethylene and hypersensitive response.</p><p id="p0015" num="0015">In the present invention is achieved, for the first time, the simultaneous activation of enzymes chitinase, beta 1, 3 glucanase, glutathione peroxidase, phenylalanine ammonia lyase, superoxide dismutase, and allene oxide synthase, which are part of the signaling pathways of salicylic acid, jasmonic acid/ethylene and the<!-- EPO <DP n="5"> --> hypersensitive response. This activation correlates with protection against bacteria, oomycetes and fungi.</p><p id="p0016" num="0016">Additionally, we demonstrate the simultaneous activation of a group of new genes, belonging to the route of salicylic acid, jasmonic acid/ethylene and hypersensitive response, whose activation correlates with protection against bacteria, oomycetes and fungi. These genes were identified and characterized by the technique of Serial Analysis of Gene Expression (SuperSAGE). It is surprising, having into account the prior state of the art, that the activation of genes that belong to the pathway of the salicylic acid, the jasmonic acid/ethylene and the hypersensitive response occur simultaneously in response to the application of a natural compound.</p><p id="p0017" num="0017">In the context of the invention said compound can be a phytohormone, a nucleic acid, a lipid or a peptide, among other compounds.</p><p id="p0018" num="0018">In one embodiment of the invention, the stimulation of the natural defense and the induction of resistance to diseases in plants by simultaneous activation of genes associated with salicylic acid, jasmonic acid/ethylene and hypersensitive response, occurs after the application of phytohormones to such plants. In a particular embodiment, the phytohormone is a natural brassinosteroid or its analogue. In the context of this invention it is considered an analogue of brassinosteroid such compound that is synthesized starting from changes in the structure of the rings of a natural brassinosteroid in order to increase its activity.</p><p id="p0019" num="0019">The method disclosed in this invention allows the preventive and curative treatment of plant diseases caused by bacteria, oomycetes and fungi through the simultaneous activation of genes related to the route of salicylic acid, jasmonic acid/ethylene and hypersensitive response. In one embodiment of the invention, the disease being treated or prevented is the "Huanglongbing" (HLB), produced by the bacterium <i>Candidatus</i> 'Liberibacter asiaticus' in citrus. In another embodiment, the disease that is treated or prevented is that caused by <i>Alternaria solani</i> in the tomato cultures, or that caused by <i>Phytophthora parasitica</i> in tobacco cultures.</p><p id="p0020" num="0020">The present invention also discloses for the first time, the concentration and application frequency of the natural brassinosteroids (and their analogues) to allow the effective control of plant diseases. In one embodiment of the invention, the application of the natural brassinosteroid or analogue, in a concentration range from 0.01 to 20 µM, allows drastic reduction of the agents that cause diseases of bacterial and fungal origin, by reducing the number of copies of the bacterium, oomycetes or<!-- EPO <DP n="6"> --> fungus, through the treatment of sick plants. The method proposed in the present invention can be used to prevent the infection of healthy plants by periodically applying a natural brassinosteroid and its analogue. In a particular embodiment of the invention, the application of the brassinosteroid to the plant occurs at least once in a month. In another embodiment, the application of the brassinosteroid to the sick plants occurs with a frequency of at least twice in a month. The range of brassinosteroid concentration to be applied, both for natural and analogue, varies depending on the crop to be protected or treated, and also depending on the application technology. As known by those skilled in this technical field, the effective concentrations of the compound may considerably decrease when a Low Volume Application or Ultra-Low Volume Application is used.</p><p id="p0021" num="0021">In one embodiment of the invention, the method of stimulating the natural defense and inducing resistance to diseases in plants involves the application of a brassinosteroid or an analogue in combination with a pesticide.</p><p id="p0022" num="0022">Another object of the present invention is a composition for stimulating the natural defense and inducing resistance to diseases in plants comprising a compound that simultaneously activates genes related to the route of the salicylic acid, the jasmonic acid/ethylene and the hypersensitivity response, and wherein said compound is a phytohormone.</p><p id="p0023" num="0023">In a preferred embodiment, said composition comprises a natural brassinosteroid or a brassinosteroid analogue. In a particular embodiment of the invention, the natural brassinosteroids and the analogues are obtained by chemical synthesis. For the purpose of the invention, the brassinosteroids can be formulated through a solution, suspension, emulsion, powder, granule, concentrate emulsifiable, aerosol, impregnated granule, adjuvant, paste or through encapsulations.</p><p id="p0024" num="0024">In one embodiment of the invention, in the composition for preventing or curing plant diseases, the natural brassinosteroid or the brassinosteroid analogue is in a range between 0.01 to 20 µM, or its equivalent for use in low or ultra -low volume.</p><p id="p0025" num="0025">Another object of the present invention is the use of a brassinosteroid to prepare a composition for the stimulation of the natural defense and the induction of resistance to diseases in plants, where the composition is periodically applied. In one embodiment of the invention the plant diseases that can be prevented or treated by this new use of the brassinosteroids are caused by a bacterium, a fungus or oomycete.<!-- EPO <DP n="7"> --></p><p id="p0026" num="0026">Another aspect of the present invention relates to a method for the prevention or treatment of the Huanglongbing (HLB) disease in citrus where a brassinosteroid is periodically applied to the plant, at least once a month. In said method the brassinosteroid can be a natural compound or a brassinosteroid analogue.</p><heading id="h0004"><b>Brief description of the drawings</b></heading><p id="p0027" num="0027"><ul><li><figref idrefs="f0001"><b>Figure 1</b></figref><b>.</b> Relative expression of genes related to defense responses to diseases in citrus plants treated with the brassinosteroid analogue (25R)-3-hydroxy-C-homo-11-oxa-5-espirostan-12-one. It shows the relative expression of genes encoding for: chitinase (A), β-1,3-glucanase (B), gluthatione peroxidase (C), phenylalanine-ammonia lyase (D), superoxide dismutase (E), alene oxide synthase (F). The bars on the curves represent the standard deviation of the mean of 10 plants for each time tested. The genes tested are related to the resistance of plants through the salicylic acid, jasmonic acid/ethylene and hypersensitivity response.</li><li><figref idrefs="f0002 f0003"><b>Figure 2</b></figref><b>.</b> Relative expression of new genes identified by the SuperSAGE technique, activated during the treatments with an analogous of brassinosteroid. The bars represent the standard deviations of the mean of 10 leaves per plant in each time points. The genes were grouped in the following categories: genes related with the defense response in plants against pathogens in general (A); genes related with the defense response in plants against bacterium (B); transcription factors related with the plant defense against disease (C); signaling to defense response (D); and genes related with the phytoalexin biosynthesis (E).</li><li><figref idrefs="f0003"><b>Figure 3</b></figref><b>.</b> Effect of a brassinosteroid analogue on the reduction of HLB in citrus plants in development (A) and adult (B), measured as copies of the HLB bacterium per reaction, determined by polymerase chain reaction (PCR). The bars on the curves represent the standard deviation of the mean of 10 leaves for each time tested.</li><li><figref idrefs="f0004"><b>Figure 4</b></figref><b>.</b> Electron microscopy of leaves from HLB infected plants treated (A) and untreated (B) with a brassinosteroid analogue. Twenty electron micrographs were made for each sample analyzed at different magnifications. We studied a total of 10 grids per sample. Each copper grid has 400 holes for viewing.</li><li><figref idrefs="f0004"><b>Figure 5</b></figref><b>.</b> Evaluation of the effect of natural brassinosteroid and analogue on the reduction of HLB, measured as copies of the HLB bacterium per reaction. The bars<!-- EPO <DP n="8"> --> on the curves represent the standard deviation of the mean of 10 plants for each time tested.</li><li><figref idrefs="f0005"><b>Figure 6</b></figref><b>.</b> Effect of the frequency of application of brassinosteroid analogue (25R)-3-hydroxy-C-homo-11-oxa-5-espirostan-12-one on reducing HLB, measured as copies of the HLB bacterium per PCR reaction. The bars on the curves represent the standard deviation of the mean of 10 leaves per plant for each time tested.</li><li><figref idrefs="f0005"><b>Figure 7</b></figref><b>.</b> Protective effect of brassinosteroid analogue (25R)-3-hydroxy-C-homo-11-oxa-5-espirostan-12-one on HLB of citrus, measured as copies of the HLB bacterium per PCR reaction. Product applications were made once a month. The bars on the curves represent the standard deviation of the mean of 10 leaves per plant for each time tested.</li></ul></p><heading id="h0005"><b>Examples</b></heading><heading id="h0006"><b>Example 1. Simultaneous activation of genes related to the natural resistance of plants to diseases after the treatment with a brassinosteroid analogue.</b></heading><p id="p0028" num="0028">Citrus plants (<i>Citrus sinensis</i>) were treated with the brassinosteroid analogue (25R)-3-hydroxy-C-homo-11-oxa-5-espirostan-12-one at 20 µM (<nplcit id="ncit0019" npl-type="s"><text>Iglesias et al. (1998) Synthetic Communications 28: 75-81</text></nplcit>). Leaves from five plants were collected at 0, 1, 5, 10, 24 and 48 hours after spray application. Total RNA was extracted from leaves using the RNeasy kit (Qiagen, Valencia, CA) according to manufacturer's instructions, which includes a DNase treatment. The cDNAs were synthesized by using oligo-dT primer and reverse transcription kit SuperScript III (Invitrogen, Carlsbad, CA) according to manufacturer's instructions. The real-time quantitative PCR was performed using a RotorGene 3000 PCR machine (Corbett, Australia) and QuantiTect SYBR Green PCR kit (Qiagen). All sequences of primers for genes related to defense against diseases of citrus plants are shown in Table 1. The reaction conditions in real-time PCR were: an initial denaturation step at 95°C for 15 min. followed by denaturation at 95°C for 15 s, an alignment step for 30 s at 60°C and an extension step for 30 s at 72 °C for 40 cycles. The analysis was carried out using the RotorGene 3000 software (Corbett, Australia) and five replicates were used for each sample. Experiments were repeated twice.<!-- EPO <DP n="9"> -->
<tables id="tabl0001" num="0001"><table frame="topbot"><title><b>Table 1.</b> List of oligonucleotides used in the experiments.</title><tgroup cols="2" colsep="0"><colspec colnum="1" colname="col1" colwidth="51mm"/><colspec colnum="2" colname="col2" colwidth="62mm"/><thead><row><entry valign="top"><b><i>Citrus sinensis</i> genes analyzed</b></entry><entry valign="top"><b>Oligonucleotides</b></entry></row></thead><tbody><row><entry>quitinase</entry><entry>5'-TCTTCGACGGCATAAAGAATCA-3'</entry></row><row><entry/><entry>5'-CCAAATTGAGGATAAGCCTTGG-3'</entry></row><row><entry>beta-1,3-glucanase</entry><entry>5'-TCGTTGGTGACCGTCAAATATC-3'</entry></row><row><entry/><entry>5'-TTTCTCCAACGCAGCGTAAGTA-3'</entry></row><row><entry>Phenylalanine ammonia- lyase</entry><entry>5'-AACGGGTTGCCTTCAAATCTTA-3'</entry></row><row><entry/><entry>5'-ACATGATTGGTGACAGGATTGG-3'</entry></row><row><entry>superoxide dismutase</entry><entry>5'-CAGTTGCAGTTCTTGGTGGAAC-3'</entry></row><row><entry/><entry>5'-AGACCAGAGAGGCTTCCTGAAA-3'</entry></row><row><entry>allene oxide synthase</entry><entry>5'-CCACACTTGGCTCGGATGC-3'</entry></row><row><entry/><entry>5'-CGTGCGGAGCAATGGTTC-3'</entry></row><row><entry>glutathione peroxidase</entry><entry>5'-GAATGTTGTTGAGCGTTATGCC-3'</entry></row><row><entry/><entry>5'-AGCTGATCATGCAAGTTGTAGCA-3'</entry></row><row><entry>actin</entry><entry>5'-GTGGCTCCACCAGAGAGAAA-3'</entry></row><row><entry/><entry>5'-TGGATGGACCAGACTCATCA-3'</entry></row></tbody></tgroup></table></tables></p><p id="p0029" num="0029"><figref idrefs="f0001">Figure 1</figref> shows as all analyzed genes were activated after treatment of citrus plants with the brassinosteroid analogue. Allene oxide synthase gene had the highest level of expression at 24 hours, while the rest of the genes had their highest expression at 5 hours after analogue was applied. This group of genes has an important role in plant defense against pathogens.</p><heading id="h0007"><b>Example 2. Identification of new genes related to the natural defense response in plants treated with a brassinosteroid analogue.</b></heading><p id="p0030" num="0030">Citrus plants (Citrus sinensis) were treated with the brassinosteroid analogue (25R)-3-hydroxy-C-homo-11-oxa-5-espirostan-12-one at 20 µM. Leaves from five plants were collected at 1, 5, 10, 24 and 48 hours after spray application. Total RNA was extracted from leaves using the RNeasy kit (Qiagen, Valencia, CA) according to manufacturer's instructions. The cDNAs were synthesized by using biotinylated oligo-dT primer and reverse transcription kit SuperScript III (Invitrogen, Carlsbad, CA) according to manufacturer's instructions. Samples of five citrus plants treated with water and collected during the times listed above were used as control. The identification and characterization of new genes was performed by the construction of two cDNA libraries by the technique of SuperSAGE (<nplcit id="ncit0020" npl-type="s"><text>Matsumura et al. (2003) PNAS 100: 15718-15723</text></nplcit>). The control library was the mixture of leaves of plants<!-- EPO <DP n="10"> --> treated with water at different times and target sample was the mixture of citrus plant leaves treated with the analogue at different times. The new genes related to plant response to the HLB, activated by application of brassinosteroid analogue, were isolated, sequenced and analyzed. <figref idrefs="f0002 f0003">Figure 2</figref> shows the new genes activated by the analogue, which are related to the natural defense mechanism of plants against diseases. Importantly, as this analogue of brassinosteroids simultaneously activates genes related to hypersensitive response, salicylic acid and jasmonic acid/ethylene, this is a new mechanism so far not described.</p><heading id="h0008"><b>Example 3. Evaluation of the effect of the application of a brassinosteroid analogue on the control of HLB of citrus in plants in the development phase and in adult plants.</b></heading><heading id="h0009"><i>a) Evaluation of the effect on citrus plants in the development phase.</i></heading><p id="p0031" num="0031">The experiment was developed under conditions of greenhouses. Plants <i>(Citrus sinensis)</i> with symptoms of HLB were placed in black plastic bags with a suitable irrigation regimen. The levels of the bacteria <i>Candidatus</i> 'Liberibacter asiaticus' in plants with symptoms of HLB were determined by real-time PCR, through the absolute quantification of bacteria (copies of bacteria per reaction) in the leaves according to the standard curve and 16S ribosomal DNA amplified from the bacteria. Quantification of bacteria was evaluated every month for 6 months. The last assessment was developed by taking all the leaves of the plant and performing a mixture prior to isolation of DNA. The concentration of the brassinosteroid analogue (25R)-3-hydroxy-C-homo-11-oxa-5-espirostan-12-one was 20 µM and was applied by spraying every 15 days. The DNA was extracted from leaves according to the protocol for isolation of DNA from Promega. The real-time quantitative PCR was performed using a RotorGene 3000 PCR machine (Corbett, Australia) and QuantiTect SYBR Green PCR kit (Qiagen). The oligos used for quantification of bacteria were: CTAATCCCCAAAAGCCATCTC and CTTCAGGCAAAACCAACTCC. The reaction conditions in real-time PCR were: an initial denaturation step at 95°C for 15 min. followed by denaturation at 95°C for 15s, an alignment step for 30 s at 60 °C and an extension step for 30 s at 72°C for 40cycles. The analysis was carried out using the RotorGene 3000 software (Corbett, Australia) and five replicates were used for each sample. Experiments were repeated twice. As controls, sick citrus plants were used, to which the brassinosteroid was not applied. As there was a significant reduction in levels of bacteria from the month, reaching undetectable<!-- EPO <DP n="11"> --> levels from month 4, the last evaluation, at the end the experiment As shown in <figref idrefs="f0003">Figure 3A</figref>, there was a significant reduction in levels of bacteria from the second month, reaching undetectable levels from month 4, which was maintained until the last evaluation, conducted at the end of the experiment. Importantly, this behavior was observed in all plants that were treated with this analogue of brassinosteroid.</p><heading id="h0010">b) <i>Evaluation of the effect on adult citrus plants.</i></heading><p id="p0032" num="0032">The experiment was developed under natural conditions. The levels of the bacteria <i>Candidatus</i> 'Liberibacter asiaticus' in 30 plants with symptoms of HLB were determined by real-time PCR, through the absolute quantification of bacteria (copies of bacteria per reaction) in the leaves according to the standard curve and 16S ribosomal DNA amplified from the bacteria. Quantification of bacteria was evaluated every month for a year. The last assessment was developed by taking all the leaves of the plant and performing a mixture prior to DNA isolation. The concentration of the brassinosteroid analogue (25R)-3-hydroxy-C-homo-11-oxa-5-espirostan-12-one was 20 mM and was applied by spraying every 15 days. DNA was extracted from leaves according to the protocol for isolation of DNA from Promega. The real-time quantitative PCR was performed as described in Example 3a. Diseased citrus plants, to which the brassinosteroid was not applied, were used as controls. As shown in <figref idrefs="f0003">Figure 3B</figref>, there was a significant reduction in bacteria levels from third months, reaching undetectable levels from months 8, a pattern that continued until the last evaluation, conducted at the end of experiment. All plants that were treated with this analogue of brassinosteroid reduced levels of bacteria.</p><heading id="h0011"><i>c) Electron microscopy of treated citrus plants.</i></heading><p id="p0033" num="0033">The objective of this experiment was the diagnosis of the bacterium <i>Candidatus</i> 'Liberibacter asiaticus' through an ultrastructural study by transmission electron microscopy in HLB infected citrus plants (<i>Citrus sinensis</i>)<i>,</i> treated with the same analogue of brassinosteroid. Leaf samples were taken from HLB (<i>Candidatus</i> 'Liberibacter asiaticus') infected citrus plants, treated for one year. As a control, leaf samples were taken from infected plant without application of the product. The different samples were fixed in glutaraldehyde 5% overnight under vacuum at 4°C and post-fixed in 1% osmium tetroxide for 12 hours at 4°C. Subsequently, the samples were washed in cacodylate buffer pH 7.4 and dehydrated in increasing concentrations of acetone (20, 30, 40, 50, 60, 70, 80, 90 and 100%) for 15 minutes each time at 4°C, except 100% that took place at room temperature for 1 hour. The<!-- EPO <DP n="12"> --> inclusion was made with low viscosity. The ultrathin sections were made with an ultramicrotome (NOVA, LKB) with a thickness of 40-50 nm, and were placed on copper grids of 400 holes. Then, the grids were contrasted with saturated uranyl acetate and lead citrate and examined with a JEOL JEM 2000 EX (JEOL). 20 electron micrographs were made for each sample analyzed at different magnifications. We studied a total of 10 grids per sample. Each copper grid has 400 holes for viewing. In treated samples the presence of bacteria was not observed (<figref idrefs="f0004">Figure 4A</figref>), whereas in the untreated citrus leaves (control) the presence of longitudinal and transverse bacteria <i>Candidatus</i> 'Liberibacter asiaticus' was observed at the ultrastructural level (<figref idrefs="f0004">Figure 4B</figref>).</p><heading id="h0012"><b>Example 4. Evaluation of different concentrations of the brassinosteroid analogue (25R)-3-hydroxy-C-homo-11-oxa-5-espirostan-12-one in the control of citrus HLB.</b></heading><p id="p0034" num="0034">The objective of this experiment was to assess the minimum concentration needed of the brassinosteroid analogue (25R)-3-hydroxy-C-homo-11-oxa-5-espirostan-12-one to control citrus HLB. Five citrus plants (<i>Citrus sinensis</i>) with HLB were used, for each concentration of the analogue. Concentrations tested were 0.001, 0.01, 0.1, 1, 5, 10, 20, 40, 60 µM, and it was applied by spraying every 15 days for 6 months. The evaluation was performed 6 months after treatment. The levels of the bacteria <i>Candidatus</i> 'Liberibacter asiaticus' were determined according to example 3a. As shown in Table 2, from the concentrations of 0.01 and up to 60 µM of brassinosteroid analogue, bacteria levels were drastically reduced.
<tables id="tabl0002" num="0002"><table frame="all"><title><b>Table 2.</b> Effect of different concentrations of the brassinosteroid analogue (25R)-3-hydroxy-C-homo-11-oxa-5-espirostan-12-one on bacteria.</title><tgroup cols="2"><colspec colnum="1" colname="col1" colwidth="76mm"/><colspec colnum="2" colname="col2" colwidth="90mm"/><thead><row><entry valign="top">Concentration of the brassinosteroid analogue (µM)</entry><entry valign="top">Absolute concentration of the bacterium after 6 months of treatment (Copies of the bacteria by reaction)</entry></row></thead><tbody><row><entry align="center">0</entry><entry align="center">2788</entry></row><row><entry align="center">0.001</entry><entry align="center">522</entry></row><row><entry align="center">0.01</entry><entry align="center">29</entry></row><row><entry align="center">1</entry><entry align="center">1</entry></row><row><entry align="center">5</entry><entry align="center">0</entry></row><row><entry align="center">10</entry><entry align="center">0</entry></row><!-- EPO <DP n="13"> --><row><entry align="center">20</entry><entry align="center">0</entry></row><row><entry align="center">40</entry><entry align="center">0</entry></row><row><entry align="center">60</entry><entry align="center">0</entry></row></tbody></tgroup></table></tables></p><heading id="h0013"><b>Example 5. Evaluation of the effect of the application of a natural brassinosteroid (brassinolide) and a brassinosteroid analogue in the control of citrus HLB.</b></heading><p id="p0035" num="0035">In order to evaluate the effect of a natural brassinosteroid (brassinolide) (<nplcit id="ncit0021" npl-type="s"><text>Khripach et al. (2000) Ann. Botany 86: 441-447</text></nplcit>) and the brassinosteroid analogue (25R)-3-hydroxy-C-homo-11-oxa-5-espirostan-12-one in the control of HLB in the same experiment, 10 HLB infected citrus plants were used for each treatment. Both compounds were applied by spray at a concentration of 1 µM every 15 days for 6 months. The levels of the bacteria <i>Candidatus</i> 'Liberibacter asiaticus' were determined according to Example 3a. <figref idrefs="f0004">Figure 5</figref> shows how both the natural and analog compound had a positive effect in achieving a significant reduction in bacteria levels during the evaluation period.</p><heading id="h0014"><b>Example 6. Evaluation of the effect of the application frequency of a brassinosteroid analogue on the control of citrus HLB.</b></heading><p id="p0036" num="0036">The objective of this experiment was to determine the influence of frequency of spray application of brassinosteroid analogue (25R)-3-hydroxy-C-homo-11-oxa-5-espirostan-12-one in the control of HLB in diseased citrus plants. Five plants were used per treatment and application frequencies were 1, 2 and 4 times per month. Analogue concentration used was 1 µM and the determinations of the bacterium level were performed every month until the sixth month. The levels of the bacteria <i>Candidatus</i> 'Liberibacter asiaticus' were determined according to Example 3a. As shown in <figref idrefs="f0005">Figure 6</figref>, bacterial reduction was observed in all tested variants. The compound application two times a month and weekly significantly reduced levels of bacteria, more early, compared with a single application per month.</p><heading id="h0015"><b>Example 7. Evaluation of the preventive effect of a brassinosteroid analogue on citrus HLB.</b></heading><p id="p0037" num="0037">This experiment was developed to determine the preventive effect of applying the analog (25R)-3-hydroxy-C-homo-11-oxa-5-espirostan-12-one twice a month at a concentration of 1 µM on citrus plants without HLB in an area with citrus plants wih HLB and high vector insect populations (Asian citrus psyllid - <i>Diaphorina citri</i>)<i>.</i> Ten<!-- EPO <DP n="14"> --> leaves were spray- applied the analogue, and other 10 leaves were used without product application. The levels of the bacteria <i>Candidatus</i> 'Liberibacter asiaticus' were determined according to example 3a. As shown in <figref idrefs="f0005">Figure 7</figref>, the analogous application of citrus plants without HLB allowed to protect them against infection from bacteria through the vector, while the plants to which the analogous was not applied, as the months passed, were increasing levels of bacteria and symptoms of HLB. This was another surprising and unexpected result, which allows the use of this method for the protection of citrus against this important disease.</p><heading id="h0016"><b>Example 8. Evaluation of the effect of the application of a natural brassinosteroid and an analogue on the control of other plant diseases.</b></heading><p id="p0038" num="0038">In order to evaluate the effect of the brassinosteroid analogue (25R)-3-hydroxy-C-homo-11-oxa-5-espirostan-12-one and a natural brassinosteroid (brassinolide), on the control of other plant diseases, experiments were conducted with tobacco and tomato plants inoculated with <i>Phytophthora parasitica</i> and <i>Alternaria solani,</i> respectively. Both the natural brassinosteroid as the analogue were applied by spraying at a concentration of 1 µM every 15 days for 3 months. The mortality rate was determined at 3 months. Table 3 shows how both brassinosteroids had a marked effect in reducing the incidence of diseases caused by these pathogens. Hundred plants were used for each treatment. Untreated plants were used as controls.
<tables id="tabl0003" num="0003"><table frame="all"><title><b>Table 3</b>. Effect of natural brassinosteroid and an analogue in the control of diseases caused by oomycetes and fungi.</title><tgroup cols="4"><colspec colnum="1" colname="col1" colwidth="56mm"/><colspec colnum="2" colname="col2" colwidth="22mm"/><colspec colnum="3" colname="col3" colwidth="42mm"/><colspec colnum="4" colname="col4" colwidth="44mm"/><thead><row><entry valign="top">Pathogen/plant</entry><entry valign="top">Control *</entry><entry align="center" valign="top">Natural brassinosteroid</entry><entry align="center" valign="top">Brassinosteroid analogue</entry></row></thead><tbody><row><entry><i>Alternaria solani</i>/tomato</entry><entry align="center">84</entry><entry align="center">12</entry><entry align="center">9</entry></row><row><entry><i>Phytophthora parasitica</i>/tobacco</entry><entry align="center">81</entry><entry align="center">13</entry><entry align="center">11</entry></row></tbody></tgroup><tgroup cols="4" rowsep="0"><colspec colnum="1" colname="col1" colwidth="56mm"/><colspec colnum="2" colname="col2" colwidth="22mm"/><colspec colnum="3" colname="col3" colwidth="42mm"/><colspec colnum="4" colname="col4" colwidth="44mm"/><tbody><row><entry namest="col1" nameend="col4" align="justify">* Values represent the percentage of mortality due to diseases caused by these pathogens.</entry></row></tbody></tgroup></table></tables></p></description><claims mxw-id="PCLM56982821" lang="EN" load-source="patent-office"><!-- EPO <DP n="15"> --><claim id="c-en-0001" num="0001"><claim-text>A method for the stimulation of the natural defense and the induction of resistance to diseases in plants <b>characterized by</b> the application to the plants of a compound that simultaneously activates genes related to the route of the salicylic acid, the jasmonic acid/ethylene and the hypersensitive response.</claim-text></claim><claim id="c-en-0002" num="0002"><claim-text>The method of claim 1 that is employed for the preventive and curative treatment of plant diseases.</claim-text></claim><claim id="c-en-0003" num="0003"><claim-text>The method of claim 1 wherein the compound that simultaneously activates genes related to the route of the salicylic acid, the jasmonic acid/ethylene and the hypersensitive response is a phytohormone.</claim-text></claim><claim id="c-en-0004" num="0004"><claim-text>The method of claim 3 wherein the phytohormone is a brassinosteroid.</claim-text></claim><claim id="c-en-0005" num="0005"><claim-text>The method of any of the claims 2 to 4 wherein the disease that is prevented or treated comprises the disease caused by <i>Candidatus</i> 'Liberibacter asiaticus' in citrus (Huanglongbing), the disease caused by <i>Alternaria solani</i> in tomato and the disease caused by <i>Phytophthora parasitica</i> in tobacco.</claim-text></claim><claim id="c-en-0006" num="0006"><claim-text>The method of claims 4 and 5 wherein the brassinosteroid is periodically applied to the plant, at least once a month.</claim-text></claim><claim id="c-en-0007" num="0007"><claim-text>The method of claim 6 wherein, in addition, a pesticide is applied to the plant.</claim-text></claim><claim id="c-en-0008" num="0008"><claim-text>A composition for the stimulation of the natural defense and the induction of resistance to diseases in plants comprising a compound that simultaneously activates genes related to the route of the salicylic acid, the jasmonic acid/ethylene and the hypersensitive response, and wherein said compound is a phytohormone.</claim-text></claim><claim id="c-en-0009" num="0009"><claim-text>The composition of claim 8 wherein the phytohormone is a natural brassinosteroid or a brassinosteroid analogue.</claim-text></claim><claim id="c-en-0010" num="0010"><claim-text>The composition of claim 9 wherein the natural brassinosteroid or the brassinosteroid analogue is obtained by chemical synthesis.</claim-text></claim><claim id="c-en-0011" num="0011"><claim-text>The composition of claim 9 wherein the natural brassinosteroid or the brassinosteroid analogue are in a range of 0.01 - 20 µM, or its equivalent for Low or Ultra-Low Volume Application.</claim-text></claim><claim id="c-en-0012" num="0012"><claim-text>Use of a brassinosteroid for the manufacture of a composition for the stimulation of the natural defense and the induction of resistance to diseases in plants, wherein the composition is periodically applied.<!-- EPO <DP n="16"> --></claim-text></claim><claim id="c-en-0013" num="0013"><claim-text>The use of claim 12 wherein the plant disease is caused by a bacterium, a fungus or oomycete.</claim-text></claim><claim id="c-en-0014" num="0014"><claim-text>The use of claim 13 wherein the disease comprises the disease caused by <i>Candidatus</i> 'Liberibacter asiaticus' in citrus (Huanglongbing), the disease caused by <i>Alternaria solani</i> in tomato and the disease caused by <i>Phytophthora parasitica</i> in tobacco.</claim-text></claim><claim id="c-en-0015" num="0015"><claim-text>The use of claim 12 wherein the brassinosteroid is a natural compound or a brassinosteroid analogue.</claim-text></claim><claim id="c-en-0016" num="0016"><claim-text>The use of claim 15 wherein the natural brassinosteroid or the analogue is applied at a concentration of 0.01 - 20 µM, or its equivalent for Low or Ultra-Low Volume Application, and at least once a month.</claim-text></claim><claim id="c-en-0017" num="0017"><claim-text>Method for the prevention or treatment of the Huanglongbing (HLB) disease in citrus plants <b>characterized by</b> the periodical application of a brassinosteroid to the plants.</claim-text></claim><claim id="c-en-0018" num="0018"><claim-text>The method of claim 17 wherein the brassinosteroid is a natural compound or an analogue, and it is applied at least once a month.</claim-text></claim></claims><drawings mxw-id="PDW16671150" load-source="patent-office"><!-- EPO <DP n="17"> --><figure id="f0001" num="1A,1B,1C,1D,1E,1F"><img id="if0001" file="imgf0001.tif" wi="165" he="228" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="18"> --><figure id="f0002" num="2A,2B,2C"><img id="if0002" file="imgf0002.tif" wi="154" he="233" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="19"> --><figure id="f0003" num="2D,2E,3A,3B"><img id="if0003" file="imgf0003.tif" wi="164" he="233" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="20"> --><figure id="f0004" num="4A,4B,5"><img id="if0004" file="imgf0004.tif" wi="165" he="224" img-content="drawing" img-format="tif"/></figure><!-- EPO <DP n="21"> --><figure id="f0005" num="6,7"><img id="if0005" file="imgf0005.tif" wi="149" he="220" img-content="drawing" img-format="tif"/></figure></drawings><search-report-data><doc-page id="srep0001" file="srep0001.tif" wi="152" he="233" type="tif"/><doc-page id="srep0002" file="srep0002.tif" wi="152" he="233" type="tif"/><doc-page id="srep0003" file="srep0003.tif" wi="152" he="233" type="tif"/></search-report-data><copyright>User acknowledges that Fairview Research LLC and its third party providers retain all right, title and interest in and to this xml under applicable copyright laws.  User acquires no ownership rights to this xml including but not limited to its format.  User hereby accepts the terms and conditions of the Licence Agreement</copyright></patent-document>
